Company news

MDxHealth SA news in 2026

MDxHealth SA's news releases, calls and decks from 2026, newest first.

View company

Mdxhealth Reports Third Quarter 2026 Financial Results

November 12, 2026

Mdxhealth to Release Third Quarter 2026 Financial Results on November 12

October 29, 2026

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

October 15, 2026

Mdxhealth Reports Second Quarter 2026 Financial Results

August 13, 2026

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13

July 30, 2026

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency

July 24, 2026

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

July 2, 2026

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial

June 29, 2026

Mdxhealth Reports Q1-2026 Results

May 13, 2026

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

April 30, 2026

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

March 16, 2026

Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results

February 25, 2026

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26

February 12, 2026

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

January 12, 2026

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

January 6, 2026

Calls in 2026

Decks in 2026